-
srdrplus.ahrq.gov/published_projects?page=46
June 23, 2021 - of evidence [SOE]: moderate for quantitative nuclear matrix protein 22 [NMP22], qualitative bladder tumor … Sensitivity increased for higher stage and grade tumors. … was associated with decreased risk of all-cause or bladder-cancer specific mortality. … Intravesical therapy appeared to be effective across subgroups defined by tumor stage, grade, multiplicity … difference between radiation therapy and no radiation therapy in clinical outcomes in patients with T1G3 cancers
-
srdrplus.ahrq.gov/published_projects?page=20
June 27, 2021 - We evaluated how patient and tumor characteristics modify treatment outcomes and how provider/hospital … CLPC versus RP or EBR plus AD through 10 years regardless of tumor risk. … Little information exists on other treatments or the effects of patient, tumor and provider factors. … 2021 Last updated on June 27, 2021 Objectives: It is required to determine KRAS mutation status in tumor … However, in some recurrent or metastatic colorectal cancer patients, tumor tissue is not available.
-
srdrplus.ahrq.gov/published_projects?page=8
May 30, 2023 - and cancer-related treatment. … and cancer–related treatment. … supplements), and the route or timing of nutrition interventions within gastrointestinal and head and neck cancers … studies in dietary supplements and nutrition support in gastrointestinal and head and neck cancers, … support, and the route or timing of nutrition interventions within gastrointestinal and head and neck cancers
-
srdrplus.ahrq.gov/published_projects?page=54
March 03, 2021 - READ MORE Published on March 03, 2021 Decision Aids for Cancer Screening and Treatment 74 Citations … updated on March 03, 2021 Objectives: Background: Many health decisions about screening and treatment for cancers … It is unclear whether the effectiveness of decision aids for decisions related to cancers differs by … We predefined three population groups of interest based on risk or presence of cancer (average cancer … risk, high cancer risk, early cancer).
-
srdrplus.ahrq.gov/published_projects?page=51
June 23, 2021 - READ MORE Published on June 23, 2021 Imaging for the Pretreatment Staging of Small Cell Lung Cancer … Last updated on June 23, 2021 Objectives: Hepatocellular carcinoma (HCC) is the most common primary malignant … neoplasm of the liver, and accurate diagnosis and staging of HCC are important for guiding treatment … MORE Published on June 23, 2021 Imaging Techniques for Treatment Evaluation for Metastatic Breast Cancer
-
srdrplus.ahrq.gov/published_projects?page=24
October 31, 2022 - READ MORE Published on June 27, 2021 Medication Use for the Risk Reduction of Primary Breast Cancer … ; tamoxifen reduced noninvasive cancer in two trials; and breast-cancer specific and all-cause mortality … In placebo-controlled trials, tamoxifen increased endometrial cancer (RR 2.25; 95% CI, 1.17 to 4.41; … In the STAR head-to-head trial, raloxifene caused fewer cases of endometrial cancer (RR 0.55; 95% CI, … Risks for thromboembolic events and endometrial cancer with tamoxifen were higher for older compared
-
srdrplus.ahrq.gov/published_projects?page=25
June 27, 2021 - Published on June 27, 2021 Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA1/2-Related Cancer … June 27, 2021 Last updated on June 27, 2021 Objectives: Background: Pathogenic mutations in breast cancer … benefits and harms of risk assessment, genetic counseling, and genetic testing for BRCA1/2-related cancer … Adverse effects included venous thromboembolic events for tamoxifen and raloxifene; endometrial cancer … In observational studies, mastectomy was associated with 90 to 100 percent reduction in breast cancer
-
srdrplus.ahrq.gov/published_projects?page=18
October 06, 2021 - , breast cancer, or melanoma. … READ MORE Published on October 06, 2021 Disparities and Barriers to Pediatric Cancer Survivorship Care … Survival rates for pediatric cancer have dramatically increased since the 1970s and the population of … childhood cancer survivors (CCS) exceed 500,000 in the US. … We used the authors’ definition of CCS; where not specified, CCS included those diagnosed with any cancer
-
srdrplus.ahrq.gov/published_projects?page=13
September 14, 2022 - 2022 The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer … , and head and neck cancer 0 Citations • 0 Key Questions • 0 Extraction Forms Project created on September … review of diagnostic accuracy and clinical impact of PET and PET-CT used for surveillance in several cancer … , and head and neck cancer 0 Citations • 4 Key Questions • 0 Extraction Forms Project created on September … review of diagnostic accuracy and clinical impact of PET and PET-CT used for surveillance in several cancer
-
srdrplus.ahrq.gov/published_projects?page=14
June 27, 2022 - READ MORE Published on June 27, 2022 Breast cancer and cardiovascular outcomes 142 Citations • 2 Key … Objectives: Q1: What is the risk for the development of cardiovascular outcomes in patients with breast cancer … Q2: What are the incidence rates of cardiovascular diseases among patients diagnosed with breast cancer
-
srdrplus.ahrq.gov/published_projects?page=55
March 01, 2021 - 2021 The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer … , and head and neck cancer 12 Citations • 4 Key Questions • 12 Extraction Forms Project created on March … review of diagnostic accuracy and clinical impact of PET and PET-CT used for surveillance in several cancer
-
srdrplus.ahrq.gov/published_projects?page=9
January 17, 2023 - and uptake of targeted preventive services (e.g., smoking cessation, recommended immunizations, lung cancer … Only three included trials reported on smoking cessation, vaccination, or lung cancer screening outcomes … READ MORE Published on January 09, 2023 Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer … 2023 Objectives: Background: Cardiovascular disease (CVD) is the leading cause of death and colorectal cancer … Risk (per 10,000 women over 4 to 5.6 years) of invasive breast cancer (51 more cases), probable dementia
-
srdrplus.ahrq.gov/published_projects?page=47
June 23, 2021 - Search for more Projects Published on June 23, 2021 Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer … Although the standard treatment for non-metastatic muscle-invasive bladder cancer is cystectomy and neoadjuvant … Evidence on harms, effectiveness of treatments for muscle-invasive bladder cancer in patient subgroups … chemotherapy with cisplatinum-based regimens improved survival in patients with muscle-invasive bladder cancer
-
srdrplus.ahrq.gov/published_projects?page=16
July 29, 2022 - READ MORE Published on December 01, 2021 Interventions for Breathlessness in Patients with Advanced Cancer … of non-pharmacological and pharmacological interventions for breathlessness in adults with advanced cancer
-
srdrplus.ahrq.gov/published_projects?page=11
October 25, 2022 - AREDS 2 trial found the AREDS formulation with beta carotene associated with increased risk of lung cancer … carotene when current smokers were excluded from the analysis (2.0% vs. 0.9%, p=0.04); almost all lung cancers … AREDS 2 trial found the AREDS formulation with beta carotene associated with increased risk of lung cancer … carotene when current smokers were excluded from the analysis (2.0% vs. 0.9%, p=0.04); almost all lung cancers
-
srdrplus.ahrq.gov/published_projects?page=52
March 07, 2023 - breast reconstruction options for women who are undergoing (or have undergone) mastectomy for breast cancer
-
srdrplus.ahrq.gov/published_projects?page=28
June 27, 2021 - increased risk of cardiovascular disease, and long-term estrogen increased risk of dementia and breast cancer
-
srdrplus.ahrq.gov/published_projects?page=43
June 27, 2021 - disparities are well-documented (e.g., papanicolaou tests for people with mobility impairments or colorectal cancer